After some Thursday drama, Shire weighs Takeda's cash-sweetened $61.5B offer

Friday, the Dublin drugmaker said it had received a new offer from Japan’s largest pharma, comprising £26 per share in new Takeda shares and and £21 per share in cash—good for £47 per share total, or about £44 billion ($61.6 billion).